Literature DB >> 14758349

Perceived outcomes and utilization of upper extremity surgical reconstruction in individuals with tetraplegia at model spinal cord injury systems.

A M Bryden1, K S Wuolle, P K Murray, P H Peckham.   

Abstract

STUDY
DESIGN: Survey.
OBJECTIVE: To measure the utilization of upper extremity reconstructive surgery and the clinicians' perceptions of the outcomes provided for persons with tetraplegia across the Model Spinal Cord (SCI) Injury Systems.
SETTING: Model SCI Systems. PARTICIPANTS: A clinician from each of the Model Centers. MAIN OUTCOME MEASURE: A mailed survey eliciting responses with respect to: (1) utilization of upper extremity reconstructive procedures and (2) the clinicians' perceived outcomes of these procedures.
RESULTS: In all, 76% responded positively about the availability and appropriateness of upper extremity surgical reconstruction at their center. Of the respondents, 75% felt that surgery recipients were generally satisfied with their surgeries, 80% felt that the surgery made a positive impact on recipients' lives, 81% felt that recipients showed increased independence, and 70% reported a positive impact on recipients' occupation. In all, 93% felt insurance companies should pay for the procedures. Compared to the satisfaction of surgery recipients using a similar instrument, clinicians anticipated slightly greater improvements in all areas except occupation.
CONCLUSIONS: There is a positive perception of the benefits of reconstructive surgery for tetraplegia; however, procedures are not routinely offered at all centers. The primary reasons reported for this include the misconception that insurance does not remit payment, that a surgeon is not available, and that surgical candidates are referred to another center.

Entities:  

Mesh:

Year:  2004        PMID: 14758349     DOI: 10.1038/sj.sc.3101579

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  8 in total

1.  Checkpoints to Progression: Qualitative Analysis of the Personal and Contextual Factors That Influence Selection of Upper Extremity Reconstruction Among Patients With Tetraplegia.

Authors:  Chelsea A Harris; John-Michael Muller; Melissa J Shauver; Kevin C Chung
Journal:  J Hand Surg Am       Date:  2017-07       Impact factor: 2.230

2.  Access to surgical upper extremity care for people with tetraplegia: an international perspective.

Authors:  P M Fox; P Suarez; V R Hentz; C M Curtin
Journal:  Spinal Cord       Date:  2015-02-17       Impact factor: 2.772

3.  Leveraging the Medical Context to Increase Upper Extremity Reconstruction Among Patients With Tetraplegia: A Qualitative Analysis.

Authors:  Chelsea A Harris; John-Michael Muller; Melissa J Shauver; Kevin C Chung
Journal:  Arch Phys Med Rehabil       Date:  2017-08-03       Impact factor: 3.966

4.  How many spinal cord injury patients can catheterize their own bladder? The epidemiology of upper extremity function as it affects bladder management.

Authors:  D V Zlatev; K Shem; C S Elliott
Journal:  Spinal Cord       Date:  2016-01-19       Impact factor: 2.772

5.  Determinants of patient satisfaction after severe lower-extremity injuries.

Authors:  Robert V O'Toole; Renan C Castillo; Andrew N Pollak; Ellen J MacKenzie; Michael J Bosse
Journal:  J Bone Joint Surg Am       Date:  2008-06       Impact factor: 5.284

6.  Satisfaction with upper extremity surgery in individuals with tetraplegia.

Authors:  Hanne Gregersen; Mille Lybæk; Inger Lauge Johannesen; Pernille Leicht; Ulla Vig Nissen; Fin Biering-Sørensen
Journal:  J Spinal Cord Med       Date:  2014-09-22       Impact factor: 1.985

7.  Nerve transfers in tetraplegia I: Background and technique.

Authors:  Justin M Brown
Journal:  Surg Neurol Int       Date:  2011-08-30

8.  Can Magnetic Resonance Imaging Reveal Lower Motor Neuron Damage after Traumatic Spinal Cord Injury? A Scoping Review.

Authors:  Jethro Moneo; John L K Kramer; Thomas E Nightingale; Michael J Berger
Journal:  Neurotrauma Rep       Date:  2021-11-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.